Patents
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
11/2006
11/14/2006CA2343099C Role of human kis (hkis) as an inhibitory kinase of the cyclin-dependentkinase inhibitor p27. compositions, methods and uses thereof to control cell proliferation
11/14/2006CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/09/2006WO2006119458A1 Gene therapy for neurometabolic disorders
11/09/2006WO2006119449A2 Modified adenovirus containing a stabilized antibody
11/09/2006WO2006119341A2 Gene therapy for spinal cord disorders
11/09/2006WO2006119150A2 Compositions and methods for targeting of viral vectors
11/09/2006WO2006119071A2 Methods and uses of leukotriene b4 hydroxylases to treat diseases
11/09/2006WO2006118564A2 MODIFIED CELLS EXPRESSING A PROTEIN THAT MODULATES ACTIVITY OF bHLH PROTEINS, AND USES THEREOF
11/09/2006WO2006118328A1 Degranulation inhibitor
11/09/2006WO2006118313A1 Novel polypeptide and use thereof
11/09/2006WO2006116873A1 Diagnosis and treatment of endometriosis
11/09/2006WO2006116867A1 Genemap of the human genes associated with crohn's disease
11/09/2006WO2006116862A1 Method for inhibiting er stress-induced apoptosis
11/09/2006WO2006079014A3 Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
11/09/2006WO2005118824A3 Methods and compositions for the inhibition of gene expression
11/09/2006WO2005117557A3 Expression system
11/09/2006WO2005089112A3 Plasma-enhanced functionalization of carbon-containing substrates
11/09/2006WO2005055948A3 Epha2, epha4 and lmw-ptp and methods of treatment of hyperproliferative cell disorders
11/09/2006US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006US20060252915 Inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity
11/09/2006US20060252724 Method and composition for modulating bone growth
11/09/2006US20060252723 Combined therapy utilizing reduction of DNA methyltransferase expression and/or activity and interferon
11/09/2006US20060252722 Oligomeric compounds and compositions for use in modulation of pri-mirnas
11/09/2006US20060252721 Potent LNA oligonucleotides for the inhibition of HIF-1a expression
11/09/2006US20060252720 Modulation of HIF1 beta expression
11/09/2006US20060252719 Compositions and methods to modulate H. influenzae pathogenesis
11/09/2006US20060252718 Sphingolipids polyalkylamine conjugates for use in transfection
11/09/2006US20060252717 Sphingoid polyalkylamine conjugates for vaccination
11/09/2006US20060252716 Method for reversing the immunosuppressive effects of the melanoma inhibitory activity "mia"
11/09/2006US20060252694 Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
11/09/2006US20060252684 Osteopontin-based cancer therapies
11/09/2006US20060252681 Pain relief agents
11/09/2006US20060252680 Genes whose expression is increased in response to stimulation by corticotropin-releasing hormone
11/09/2006US20060252679 Preventive and/or trerapeutic drgs for itch
11/09/2006US20060252678 Lowering circulating free fatty acid levels, reducing body mass, maintaining weight loss, and treating obesity-related diseases and disorders
11/09/2006US20060252672 Protein N-glycosylation of eukaryotic cells using dolichol-linked oligosaccharide synthesis pathway, other N-gylosylation-increasing methods, and engineered hosts expressing products with increased N-glycosylation
11/09/2006US20060252125 ICE/CED-3 like protease designated FMH-1
11/09/2006US20060252122 A tumor necrosis factor related ligand
11/09/2006US20060252100 Can be used for the treatment of diabetes or for delaying the onset of diabetes
11/09/2006US20060252037 Expression vector comprising antisense nuclelotide sequence which decrease exxpression from kinase suppressor of RAS (KRAS) for use in the treatment and prevention of cell proliferative disorders
11/09/2006US20060252036 Alteration of rab38 function to modulate mammalian pigmentation
11/09/2006US20060251701 Localized delivery of nucleic acid by polyelectrolyte assemblies
11/09/2006US20060251683 Directly injectable formulations which provide enhanced cryoprotection of cell products
11/09/2006US20060251682 soluble and stable in physiological media; have an additional Cys residue compared with the wild type; utilised for the therapy of grass pollen-induced allergies
11/09/2006US20060251677 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
11/09/2006US20060251674 Formulations and process for production of Bordetella bronchiseptica P68 antigen and vaccines
11/09/2006US20060251667 Recombinant nucleic acid useful for inducing protective immune response against allergens
11/09/2006US20060251665 Vaccines
11/09/2006US20060251662 diagnosing the presence of a multiple myeloma tumor in a mammal; antitumor agents; identify polypeptides, cell membrane-associated, secreted or intracellular polypeptides whose expression is specifically limited to only a single (or very limited number of different) tissue type(s)
11/09/2006US20060251659 Method for screening molecules that restore NOD1 activity in cells containing an NOD2 mutation that reduces or eliminates NOD1 activity
11/09/2006US20060251650 Preventing angiogenesis by administering an antibody, or fragment, that specifically binds an extracellular domain of a neuropilin receptor; inhibiting endothelial growth factors (VEGF) from binding to the receptor; anticarcinogenic and antimetastasis agents
11/09/2006US20060251648 Nucleotide sequences coding transport protein for use in identifying modulators for treatment of pain; flavor enhancement
11/09/2006US20060251635 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them
11/09/2006US20060251632 Modulation of myostatin and use thereof in cell transplantation-based treatment of muscle disease
11/09/2006US20060251631 Treatment of joint disease, methods and apparatuses therefor
11/09/2006US20060251630 Encapsulated cell therapy
11/09/2006US20060251627 Targeted vectors for cancer immunotherapy
11/09/2006US20060251626 Efficient and stable in vivo gene transfer to cardiomyocytes using recombinant adeno-associated virus vectors
11/09/2006US20060251625 MCV MC160 compositions and methods
11/09/2006US20060251624 Cells exhibiting neuronal cell progenitor characteristics and methods of making them
11/09/2006US20060251623 Packaged virus-like particles
11/09/2006US20060251622 Container for serum production and method of regenerative medicine using the same
11/09/2006US20060251621 Ocular gene therapy
11/09/2006US20060251620 Inducible alphaviral/orip based gene expression system
11/09/2006US20060251616 Migration of hematopoietic stem cells and progenitor cells to the liver
11/09/2006US20060251604 Method for diagnosing alopecia
11/09/2006CA2609561A1 Polypeptide, vaccine and use thereof
11/09/2006CA2607341A1 Diagnosis and treatment of endometriosis
11/09/2006CA2607173A1 Gene therapy for neurometabolic disorders
11/09/2006CA2607150A1 Glucagon-like-peptide-2 (glp-2) analogues
11/09/2006CA2606858A1 Permeable capsules
11/09/2006CA2606490A1 Gene therapy for spinal cord disorders
11/09/2006CA2606341A1 Genemap of the human genes associated with crohn's disease
11/09/2006CA2606177A1 Novel polypeptide and use thereof
11/08/2006EP1719780A2 Mammalian cytokine-like polypeptide-10
11/08/2006EP1719779A2 Antibodies against Matin
11/08/2006EP1718762A1 Antisense oligonucleotide modulation of stat3 expression
11/08/2006EP1718659A1 Vectors having both isoforms of beta-hexosaminidase and uses of the same
11/08/2006EP1718274A2 Controlled and sustained delivery of nucleic acid-based therapeutic agents
11/08/2006EP1265920B1 Angiogenesis-associated proteins, and nucleic acids encoding the same
11/08/2006EP0759695B1 A method of inducing an immune response using vaccinia virus recombinants, expressing the gm-csf gene
11/08/2006CN1860228A Staple type oligonucleotide and drug comprising the same
11/08/2006CN1860127A Inhibition of SyK kinase expression
11/08/2006CN1859926A Polymer encapsulation of adenoviruses
11/08/2006CN1858205A Antisense oligonucleotide structure and use for inhibiting epidermal regulator EREG gene expression
11/08/2006CN1857738A Recombinant adenovirus vector for the gene therapy of rheumatoid arthritis
11/08/2006CN1857737A Use of Ig CDR3 gene antisense in preparing tumor treating medicine
11/08/2006CN1857232A Biodegradable nano magnetic capsule loading medicine and its preparing process
11/08/2006CN1857231A Preparing process of biodegradable capsule loading medicine and nano magnetic particle
11/08/2006CN1857224A Preparing process of nano c-FLIP antisense oligonucleotide particle
11/08/2006CN1283803C Attenuated HSV-1 vector for gene therapy
11/08/2006CN1283802C Recombinant adenovirus and its application in malignant tumor treatment
11/08/2006CN1283798C Polypeptides and polynucleotides from coagulase-negative staphylocoui
11/08/2006CN1283319C Tumor vaccine constituting method by combining dendritic cell multiplication and chemotaxis factor and suicide gene
11/08/2006CN1283313C Use of alpha-helix apolipoprotein or HDL-related protein in preparing drugs for prevention and treatment of restenosis by local administration
11/07/2006US7132521 Molecular regulatory circuits to achieve sustained activation of genes of interest by a single stress
11/07/2006US7132507 Nucleotide sequences coding polypeptide for use in the treatment of cancer
11/07/2006US7132407 N'-neu-IL-2 fusion gene controlled by a cytomegalo virus promoter
11/07/2006US7132406 Stimulation of cellular regeneration and differentiation in the inner ear
11/07/2006US7132405 Targeting vector to the urokinase plasminogen activator receptor